CRT-D device reduces hospital admissions for mild cardiac symptoms

09/1/2009 | Boston Globe (tiered subscription model), The

A combination of defibrillator and a cardiac-resynchronization therapy device proved effective in reducing the chances of patients being hospitalized for less severe forms of cardiac failure, according to a study sponsored by Boston Scientific. By the end of the year, Boston Scientific will ask the FDA to grant "indication expansion" for the CRT-D device, which was already approved for use in those with advanced forms of congestive heart failure, said Fred Colen, president of the company's cardiac rhythm management unit.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA